Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > James Christopher Frankenfield > Profile

James Christopher Frankenfield

Affiliations

  • Chief Financial Officer at Xilio Therapeutics Inc. (XLO), 2025-04-16
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
XLO $0.98 6,954 $6,840.65 12,421 2025-01-02 Filing